Skip to content
healthcare.dev

Unda 44

NDC 62106-1143, Inula helenium Root, Juniperus communis berry, Uva-ursi Leaf, Dulcamara Stem and Leaf, Cytisus scoparius Aerial Parts, Stigmata maidis Style and Stigma, Argentum metallicum, Aurum metallicum, liquid, from Seroyal USA.

Product NDC
62106-1143
Status
Listed
Labeler
Seroyal USA
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62106-1143 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GOLD12 [hp_X]/20mL
  • SILVER12 [hp_X]/20mL
  • JUNIPER BERRY4 [hp_X]/20mL
  • ARCTOSTAPHYLOS UVA-URSI LEAF4 [hp_X]/20mL
  • SOLANUM DULCAMARA STEM4 [hp_X]/20mL
  • CYTISUS SCOPARIUS FLOWERING TOP4 [hp_X]/20mL
  • CORN SILK4 [hp_X]/20mL
  • INULA HELENIUM ROOT4 [hp_X]/20mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Plant Proteins [CS]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
62106-1143-8621061143081 BOTTLE, GLASS in 1 BOX (62106-1143-8) / 20 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62106-1143 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62106-1143 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62106-1143. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.